{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:35:46Z","timestamp":1791387346472,"version":"4.3.3"},"reference-count":26,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1210\/jc.2017-01555","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T17:59:56Z","timestamp":1509559196000},"page":"271-280","source":"Crossref","is-referenced-by-count":62,"title":["PTH(1\u201334) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life"],"prefix":"10.1210","volume":"103","author":[{"given":"Andrea","family":"Palermo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"Santonati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Tabacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pedone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Raggiunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Doris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Manfrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Vescini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"issue":"6","key":"key\n\t\t\t\t20180105135246_B1","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Management of hypoparathyroidism: summary statement and guidelines","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180105135246_B2","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"European Society of Endocrinology","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180105135246_B3","unstructured":"United States Food and Drug Administration. NATPARA package insert. 2015. Available at: http:\/\/www.fda.gov\/Drugs\/ InformationOnDrugs\/ucm435518.htm. Accessed 9 May 2016."},{"issue":"7","key":"key\n\t\t\t\t20180105135246_B4","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1210\/jc.2015-4135","article-title":"Therapy of hypoparathyroidism with PTH(1\u201384): a prospective six year investigation of efficacy and safety","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180105135246_B5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t20180105135246_B6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12020-016-1141-0","article-title":"Effects of parathyroid hormone rhPTH(1\u201384) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study","volume":"55","year":"2017","journal-title":"Endocrine"},{"issue":"11","key":"key\n\t\t\t\t20180105135246_B7","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1210\/jc.2016-2530","article-title":"PTH(1\u201334) for the primary prevention of postthyroidectomy hypocalcemia: the THYPOS Trial","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t20180105135246_B8","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1\u201334 versus calcitriol and calcium","volume":"95","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t20180105135246_B9","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1\u201334) versus calcitriol and calcium","volume":"88","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t20180105135246_B10","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1\u201334 in treatment of hypoparathyroidism","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key\n\t\t\t\t20180105135246_B11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1\u201334 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","year":"1996","journal-title":"JAMA"},{"issue":"3","key":"key\n\t\t\t\t20180105135246_B12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2014.04.060","article-title":"Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1\u201334 in children with severe congenital hypoparathyroidism","volume":"165","year":"2014","journal-title":"J Pediatr"},{"issue":"2","key":"key\n\t\t\t\t20180105135246_B13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jc.2011-1908","article-title":"Synthetic human parathyroid hormone 1\u201334 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t20180105135246_B14","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/jc.2015-1855","article-title":"PTH(1\u201334) for surgical hypoparathyroidism: a prospective, open-label investigation of efficacy and quality of life","volume":"100","author":"Hypoparathyroidism AME Group","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20180105135246_B15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.ejcn.1601278","article-title":"Validation of a food frequency questionnaire for nutritional calcium intake assessment in Italian women","volume":"56","year":"2002","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"key\n\t\t\t\t20180105135246_B16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6890-8-12","article-title":"Derivation and internal validation of an equation for albumin-adjusted calcium","volume":"8","year":"2008","journal-title":"BMC Clin Pathol"},{"issue":"6","key":"key\n\t\t\t\t20180105135246_B17","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1210\/jc.2013-1239","article-title":"The effect of PTH(1\u201384) on quality of life in hypoparathyroidism","volume":"98","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t20180105135246_B18","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1210\/jc.2014-2267","article-title":"PTH(1\u201384) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t20180105135246_B19","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","article-title":"Effects of PTH(1\u201384) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial","volume":"25","year":"2014","journal-title":"Osteoporos Int"},{"issue":"5","key":"key\n\t\t\t\t20180105135246_B20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/14740338.2017.1311322","article-title":"Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism","volume":"16","year":"2017","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"key\n\t\t\t\t20180105135246_B21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11914-008-0003-y","article-title":"Safety of parathyroid hormone for the treatment of osteoporosis","volume":"6","year":"2008","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"key\n\t\t\t\t20180105135246_B22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/jc.2012-2984","article-title":"Therapy of hypoparathyroidism with PTH(1\u201384): a prospective four-year investigation of efficacy and safety","volume":"98","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20180105135246_B23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4158\/EP15936.OR","article-title":"An open-label extension study of parathyroid hormone rhPTH(1\u201384) in adults with hypoparathyroidism","volume":"22","year":"2016","journal-title":"Endocr Pract"},{"issue":"11","key":"key\n\t\t\t\t20180105135246_B24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1080\/14712598.2016.1238455","article-title":"Natpara for the treatment of hypoparathyroidism","volume":"16","year":"2016","journal-title":"Expert Opin Biol Ther"},{"issue":"11","key":"key\n\t\t\t\t20180105135246_B25","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","year":"2010","journal-title":"Osteoporos Int"},{"issue":"10","key":"key\n\t\t\t\t20180105135246_B26","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1\u201384) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Hypoparathyroid Study Group","year":"2011","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/1\/271\/23270227\/jc.2017-01555.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T18:31:47Z","timestamp":1515177107000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jcem\/article\/103\/1\/271\/4584212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,11,1]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-01555","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732070907.793576364","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,11,1]]}}}